Patent necessity: intellectual property dilemmas in the biotech domain and treatment equity for developing countries.
Spectar
J M
JM
Rockefeller College, Princeton University, USA.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy / Q000191:economics; D044966:Anti-Retroviral Agents / Q000191:economics*; D044822:Biodiversity; D001709:Biotechnology / Q000331:legislation & jurisprudence; D003132:Commerce / Q000331:legislation & jurisprudence*; D019049:Developed Countries / Q000191:economics; D003906:Developing Countries / Q000191:economics; D016527:Drug Costs / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence; D014943:Global Health; D006297:Health Services Accessibility / Q000191:economics / Q000331:legislation & jurisprudence; D006801:Humans; D018973:Intellectual Property; D007391:International Cooperation; D007883:Legislation, Medical; D008004:Licensure / Q000331:legislation & jurisprudence; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D010946:Plants, Medicinal / Q000235:genetics; D012935:Social Justice / Q000191:economics* / Q000331:legislation & jurisprudence*; D013019:South Africa; D014481:United States
D044966:Anti-Retroviral Agents